Media Relations

Twitter iconYouTube iconFacebook iconSoundCloud

Call us: +44 (0)20 7679 9041


The UCL Media Relations team is the university’s central press office.


We connect journalists to expert academics and promote UCL research and teaching throughout the global media.


More contact information


Feed icon

Press Releases

Parakeet

Mapping movements of alien bird species

The global map of alien bird species has been produced for the first time by a UCL-led team of researchers. It shows that human activities are the main determinants of how many alien bird species live in an area but that alien species are most successful in areas already rich with native bird species. More...

Published: Jan 13, 2017 8:46:26 AM

fly

High-sugar diet programmes a short lifespan in flies

Flies with a history of eating a high sugar diet live shorter lives, even after their diet improves. This is because the unhealthy diet drives long-term reprogramming of gene expression, according to a UCL-led team of researchers. More...

Published: Jan 10, 2017 5:22:26 PM

Supermarket shelves

New model predicts when people are willing to try new things

A new model to predict when people are most likely to try different products has been developed by scientists at UCL and dunnhumby, a customer science company. More...

Published: Jan 10, 2017 1:05:03 PM

Future-Element-I

Sex cells evolved to pass on quality mitochondria

Mammals immortalise their genes through eggs and sperm to ensure future generations inherit good quality mitochondria to power the body’s cells, according to new UCL research. More...

Published: Dec 21, 2016 9:22:23 AM

Brain

Gene discovery helps children with movement disorder walk again

UCL researchers have discovered a new genetic cause for dystonia, a movement disorder, enabling treatment with Deep Brain Stimulation which has been so successful that children have been able to walk again. More...

Published: Dec 20, 2016 11:08:49 AM

Professor Mark Emberton

Light therapy effectively treats early prostate cancer

A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment. More...

Published: Dec 20, 2016 9:29:15 AM